Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow
-
最新报道：Moderna announced plans to cut 10% of its workforce as COVID-19 vaccine sales decline, aiming to reduce costs by $500 million annually. The biotech firm reported a 30% drop in vaccine revenue last quarter, reflecting lower global demand. CEO Stéphane Bancel stated the restructuring will focus on streamlining operations while maintaining investment in mRNA pipeline development, including flu and cancer vaccines. Moderna shares fell 4% following the news, continuing a 50% decline over the past year. The layoffs affect approximately 500 employees across R&D and commercial divisions. Analysts note this marks Moderna's first major downsizing since becoming profitable during the pandemic.
下一篇
High-Yield Savings Top 5.00% APY as Fed Holds Rates Amid Inflation Concerns
- The Federal Reserve has maintained interest rates at 5.25%-5.50%, keeping high-yield savin...
24小时热点
热点专题
407106